NM_031229.4:c.896_899delAGTG
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_031229.4(RBCK1):c.896_899delAGTG(p.Glu299ValfsTer46) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000148 in 1,415,042 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_031229.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- polyglucosan body myopathy 1 with or without immunodeficiencyInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
- autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- polyglucosan body myopathy type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_031229.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RBCK1 | NM_031229.4 | MANE Select | c.896_899delAGTG | p.Glu299ValfsTer46 | frameshift | Exon 7 of 12 | NP_112506.2 | ||
| RBCK1 | NM_001410770.1 | c.947_950delAGTG | p.Glu316ValfsTer46 | frameshift | Exon 7 of 12 | NP_001397699.1 | |||
| RBCK1 | NM_006462.6 | c.770_773delAGTG | p.Glu257ValfsTer46 | frameshift | Exon 6 of 11 | NP_006453.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RBCK1 | ENST00000356286.10 | TSL:1 MANE Select | c.896_899delAGTG | p.Glu299ValfsTer46 | frameshift | Exon 7 of 12 | ENSP00000348632.6 | ||
| RBCK1 | ENST00000353660.7 | TSL:1 | c.770_773delAGTG | p.Glu257ValfsTer46 | frameshift | Exon 6 of 11 | ENSP00000254960.5 | ||
| RBCK1 | ENST00000382181.2 | TSL:1 | n.631-1117_631-1114delAGTG | intron | N/A | ENSP00000371616.3 |
Frequencies
GnomAD3 genomes Cov.: 27
GnomAD2 exomes AF: 0.0000114 AC: 2AN: 175738 AF XY: 0.0000211 show subpopulations
GnomAD4 exome AF: 0.0000148 AC: 21AN: 1415042Hom.: 0 AF XY: 0.0000143 AC XY: 10AN XY: 699810 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 27
ClinVar
Submissions by phenotype
Polyglucosan body myopathy type 1 Pathogenic:4
This sequence change creates a premature translational stop signal (p.Glu299Valfs*46) in the RBCK1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RBCK1 are known to be pathogenic (PMID: 2379848, 23104095, 23889995). This variant is present in population databases (rs727503764, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with clinical features of polyglucosan body myopathy with or without immunodeficiency (PMID: 23798481, 29260357, 31407473). ClinVar contains an entry for this variant (Variation ID: 140625). For these reasons, this variant has been classified as Pathogenic.
PVS1, PS4_moderate, PM2
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at